12-94834510-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000405395.2(KRT19P2):n.57G>C variant causes a non coding transcript exon change. The variant allele was found at a frequency of 0.0819 in 556,072 control chromosomes in the GnomAD database, including 2,721 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.067 ( 575 hom., cov: 33)
Exomes 𝑓: 0.088 ( 2146 hom. )
Consequence
KRT19P2
ENST00000405395.2 non_coding_transcript_exon
ENST00000405395.2 non_coding_transcript_exon
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 5.04
Publications
58 publications found
Genes affected
KRT19P2 (HGNC:33423): (keratin 19 pseudogene 2)
MIR492 (HGNC:32081): (microRNA 492) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KRT19P2 | ENST00000405395.2 | n.57G>C | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| KRT19P2 | ENST00000557173.1 | n.364G>C | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| MIR492 | ENST00000638676.1 | n.113G>C | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0669 AC: 10185AN: 152184Hom.: 573 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
10185
AN:
152184
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0974 AC: 24464AN: 251230 AF XY: 0.0939 show subpopulations
GnomAD2 exomes
AF:
AC:
24464
AN:
251230
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0876 AC: 35365AN: 403770Hom.: 2146 Cov.: 0 AF XY: 0.0858 AC XY: 19657AN XY: 229082 show subpopulations
GnomAD4 exome
AF:
AC:
35365
AN:
403770
Hom.:
Cov.:
0
AF XY:
AC XY:
19657
AN XY:
229082
show subpopulations
African (AFR)
AF:
AC:
199
AN:
11062
American (AMR)
AF:
AC:
7032
AN:
36948
Ashkenazi Jewish (ASJ)
AF:
AC:
901
AN:
12540
East Asian (EAS)
AF:
AC:
3592
AN:
15072
South Asian (SAS)
AF:
AC:
6607
AN:
67834
European-Finnish (FIN)
AF:
AC:
3310
AN:
33638
Middle Eastern (MID)
AF:
AC:
145
AN:
2602
European-Non Finnish (NFE)
AF:
AC:
12112
AN:
205908
Other (OTH)
AF:
AC:
1467
AN:
18166
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1931
3862
5792
7723
9654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
260
520
780
1040
1300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0670 AC: 10198AN: 152302Hom.: 575 Cov.: 33 AF XY: 0.0725 AC XY: 5400AN XY: 74468 show subpopulations
GnomAD4 genome
AF:
AC:
10198
AN:
152302
Hom.:
Cov.:
33
AF XY:
AC XY:
5400
AN XY:
74468
show subpopulations
African (AFR)
AF:
AC:
721
AN:
41592
American (AMR)
AF:
AC:
2076
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
276
AN:
3468
East Asian (EAS)
AF:
AC:
1276
AN:
5172
South Asian (SAS)
AF:
AC:
491
AN:
4828
European-Finnish (FIN)
AF:
AC:
1109
AN:
10602
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4081
AN:
68026
Other (OTH)
AF:
AC:
154
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
472
945
1417
1890
2362
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
466
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.